David Matuskey Selected Research

Biomarkers (Surrogate Marker)

2/2024	Synaptic loss and its association with symptom severity in Parkinson's disease.
2/2024	The Relationship of Cerebrospinal Fluid Biomarkers and Cognitive Performance in Frontotemporal Dementia.
1/2024	Relationship between Neuroimaging and Cognition in Frontotemporal Dementia: A [ 18 F]FDG PET and Structural MRI Study.
12/2020	PTSD is associated with neuroimmune suppression: evidence from PET imaging and postmortem transcriptomic studies.
8/2010	Biological markers of the effects of intravenous methylphenidate on improving inhibitory control in cocaine-dependent patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David Matuskey Research Topics

Disease

4	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2022 - 01/2017
4	Cocaine-Related Disorders (Cocaine Addiction) 01/2019 - 08/2010
3	Alzheimer Disease (Alzheimer's Disease) 02/2024 - 01/2020
3	Parkinson Disease (Parkinson's Disease) 02/2024 - 01/2020
3	Major Depressive Disorder (Major Depressive Disorders) 01/2023 - 07/2017
3	Wounds and Injuries (Trauma) 10/2021 - 01/2017
3	Substance-Related Disorders (Drug Abuse) 12/2019 - 06/2014
2	Alcoholism (Alcohol Abuse) 03/2024 - 12/2019
2	Neurodegenerative Diseases (Neurodegenerative Disease) 02/2024 - 01/2022
2	Essential Tremor (Essential Tremors) 10/2023 - 05/2023
2	Inflammation (Inflammations) 11/2022 - 10/2015
2	Mental Disorders (Mental Disorder) 01/2022 - 11/2020
2	Obesity 01/2021 - 01/2020
2	Cognitive Dysfunction 01/2020 - 01/2020
1	Opioid-Related Disorders (Opiate Addiction) 05/2024
1	Substance Withdrawal Syndrome (Withdrawal Symptoms) 05/2024
1	Frontotemporal Dementia (Semantic Dementia) 02/2024
1	Atrophy 01/2024
1	Disease Progression 01/2024
1	Bipolar Disorder (Manic Depressive Psychosis) 01/2023
1	Tobacco Use Disorder (Nicotine Dependence) 10/2022
1	Autistic Disorder (Autism) 12/2021
1	Insulin Resistance 01/2020
1	Schizophrenia (Dementia Praecox) 01/2020
1	Hyperglycemia 01/2020
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2020

Drug/Important Bio-Agent (IBA)

7	Dopamine (Intropin)FDA LinkGeneric 11/2022 - 06/2014
5	Biomarkers (Surrogate Marker)IBA 02/2024 - 08/2010
4	Metabotropic Glutamate 5 ReceptorIBA 01/2023 - 01/2017
3	Hydrocortisone (Cortisol)FDA LinkGeneric 03/2024 - 01/2020
3	Glycoproteins (Glycoprotein)IBA 10/2023 - 01/2020
3	Proteins (Proteins, Gene)FDA Link 10/2021 - 01/2017
3	Cocaine (Cocaine HCl)IBA 01/2021 - 06/2014
3	Glutamic Acid (Glutamate)FDA Link 11/2020 - 01/2017
2	Dynorphins (Dynorphin)IBA 05/2024 - 01/2019
2	Amyloid (Amyloid Fibrils)IBA 02/2024 - 01/2022
2	EnzymesIBA 10/2021 - 01/2020
2	GlucocorticoidsIBA 10/2021 - 01/2017
2	naxagolideIBA 01/2021 - 01/2020
2	Methylphenidate (Ritalin)FDA LinkGeneric 12/2019 - 08/2010
1	Opioid Analgesics (Opioids)IBA 05/2024
1	Threonine (L-Threonine)FDA Link 02/2024
1	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 02/2024
1	neuromelaninIBA 02/2024
1	Glucose (Dextrose)FDA LinkGeneric 01/2024
1	LSN3172176IBA 08/2023
1	LipopolysaccharidesIBA 11/2022
1	Nicotine FDA Link 10/2022
1	Antidepressive Agents (Antidepressants)IBA 01/2022
1	Ketamine FDA LinkGeneric 01/2022
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2022
1	Oxidoreductases (Dehydrogenase)IBA 10/2021
1	AS2471907IBA 10/2021
1	C-Reactive ProteinIBA 12/2020
1	5-HT2A Serotonin Receptor (5 HT2A Receptor)IBA 01/2020
1	Antipsychotic Agents (Antipsychotics)IBA 01/2020
1	GSK215083IBA 01/2020
1	serotonin 6 receptorIBA 01/2020
1	kappa Opioid Receptors (kappa Opioid Receptor)IBA 01/2019
1	CytokinesIBA 10/2015

Therapy/Procedure

2	Therapeutics 01/2022 - 11/2013
1	Transcranial Magnetic Stimulation 12/2021